NCT05567120

Brief Summary

The proposed pre-pilot project seeks to adapt an evidence-based psychosocial intervention-Pain Adaptation Therapy (PATH)-that employs emotion regulation, behavioral activation, and problem-solving skills training, that will be augmented with a caregiver (CG) education component, for use by CGs of individuals with Alzheimer's Disease and Related Dementias (ADRD).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 5, 2022

Completed
2.2 years until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 31, 2025

Status Verified

January 1, 2025

Enrollment Period

11 months

First QC Date

September 30, 2022

Last Update Submit

January 29, 2025

Conditions

Keywords

Caregiver

Outcome Measures

Primary Outcomes (3)

  • Change in Positive and Negative Affect as Measured by the Positive and Negative Affect Scale (PANAS)

    The 20-item self-report Positive and Negative Affect Scale (PANAS-GEN) asks participants to describe to what extent they feel different feelings and emotions on average. Respondents answer on a five-point scale: 1=Very slightly or not at all, 2=A little, 3=Moderately, 4=Quite a bit, 5=Extremely. There are different subscales within this measure with 10 questions measuring positive affect, and 10 measuring negative affect. These have scores ranging from 10-50 with a higher score indicating higher positive affect, and a lower score indicating lower negative affect respectively.

    At baseline; at week 10 (post-intervention)

  • Change in depression as measured by Montgomery-Asberg Depression Rating Scale (MADRS-S)

    The 9-item self-report Montgomery-Asberg Depression Rating Scale asks participants about items like sadness, inner tension, sleep, and concentration. Respondents answer on a 7-point scale loosely by: 0=Normal, 2=Slight reduction, 4=Moderate reduction, and 6=Completely unable. These responses are personalized to the question a little more specifically. Scores range from 0-54 with a higher score indicating higher depression.

    At baseline; at week 10 (post-intervention)

  • Change in caregiver burden as measured by Zarit Burden Interveiw (ZBI-12)

    The 12-item self-report Zarit Burden Interview Scale asks participants "do you feel...?" with responses about caregiver burden like anger, stress, and social life. Respondents answer on a 5-point scale: 0= Never, 1=Rarely, 2=Sometimes, 3=Quite Frequently, 4=Nearly Always. Scores range from 0-48 with a higher score indicating higher burden.

    At baseline; at week 10 (post-intervention)

Secondary Outcomes (6)

  • Change in efficacy and preparedness as measured by the Preparedness Caregiving Scale (PCS)

    At baseline; at week 10 (post-intervention)

  • Change in emotion regulatory ability as measured by the Emotion Regulation Questionnaire (CERQ)

    At baseline; at week 10 (post-intervention)

  • Change in positive aspects of caregiving as measured by the Positive Aspects of Caregiving scale (PAC)

    At baseline; at week 10 (post-intervention)

  • Feasibility, Acceptability, and Usability of PATH-Care intervention

    At week 10 (post-intervention)

  • Satisfaction as measured by Client Satisfaction Questionnaire (CSQ-3)

    At week 10 (post-intervention)

  • +1 more secondary outcomes

Study Arms (1)

PATH-Care

OTHER

Problem Adaptation THerapy (PATH) adapted for caregivers along with tablet based exercises to enhance and reinforce the therapy sessions.

Other: PATH-Care

Interventions

Individuals will receive the 8-session PATH-Care intervention, delivered virtually (via videoconference or phone) to mitigate negative emotions and stress experienced by informal caregivers of individuals with ADRD. The therapist in the first session will also guide the participant in the tablet-based exercises (WELLPath).

PATH-Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18
  • English speaking
  • Informal caregiver of an individual with ADRD diagnosis
  • Lives with or near the care recipient
  • Provides at least 10 hours of care per week to a person with ADRD
  • Has provided care to a person with ADRD for 6 months or more, prior to enrollment
  • Cognitively intact (Score of ≥ 26 on adjusted MoCA-Blind)
  • Score of ≥ 12 on the Negative Affect Scale of Positive and Negative Affect Schedule OR at least one significant negative emotion (score of ≥ 3)

You may not qualify if:

  • Age ≤ 18
  • Non-English speaking
  • Paid caregiver
  • Care recipient does not have ADRD diagnosis
  • Provides care for less than 10 hours per week
  • Has provided care for less than 6 months, prior to enrollment
  • Care recipient is currently enrolled in hospice
  • Meets criteria for severe Major Depression (Montgomery Asberg Depression Rating Scale ≥ 30) that may require hospitalization
  • Significant Cognitive impairment (Score of \< 26 on adjusted MoCA-Blind)
  • Score of \< 12 on the Negative Affect Scale of Positive and Negative Affect Schedule or no significant negative emotion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NewYork-Presbyterian - Weill Cornell Medicine

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Caregiver Burden

Condition Hierarchy (Ancestors)

Stress, PsychologicalBehavioral SymptomsBehavior

Study Officials

  • Cary Reid, MD PhD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2022

First Posted

October 5, 2022

Study Start

January 1, 2025

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

January 31, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations